Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
8,851 Dovepress* 5,799 1,975+ 537 7,774
PubMed Central* 0 1,077 147 1,077
Totals 5,799 3,052 684 8,851
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
214 0 0 0 3 211

View citations on PubMed Central and Google Scholar